Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from VERU

June 25, 2025 1. A Virtual Conversation with Heather Cox Richardson and DNC Chair Ken Martin — next Monday at 3pm Eastern, 12pm Pacific. If you’re not...

Saving Advice

3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according to Wall Street.

Barchart

Veru Stock Plummets 54% After FDA Advisors Vote Down Cancer-Turned-Covid Drug

Veru stock collapsed Thursday after the FDA's advisors voted against the company's cancer drug turned Covid treatment.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid

Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment.

Investors Business Daily

Why Veru Stock Is Soaring

Veru Inc (NASDAQ: VERU) shares are trading higher Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute res

Benzinga

Veru's Return On Capital Employed Insights

Veru (NASDAQ:VERU) brought in sales totaling $13.03 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 122.22%, resulting in a loss of $14.18 million.

Benzinga

Veru Seeks FDA Emergency Use Nod For Its COVID-19 Treatment

Veru Inc (NASDAQ:VERU) has submitted an emergency use authorization (EUA) for sabizabulin application to FDA for COVID-19 treatment. The application covers moderate to severe hospitalized COVID-19 patients at high risk for developing Acute Respiratory Distress Syndrome (ARDS). The EUA submission is based on the positive results from the Phase 3 COVID-19 clinical trial…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Analyst Ratings for Veru

Over the past 3 months, 4 analysts have published their opinion on Veru (NASDAQ:VERU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

So What's Up With Veru Shares Rising Today?

Shares of companies in the broader consumer staples sector, including Veru Inc (NASDAQ: VERU), are trading higher as stocks rebound from recent weakness. Stocks have experienced volatility this year amid Fed policy tightening measures.

Benzinga

Veru Whale Trades For May 16

A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 14 strange trades.

Benzinga

How Is The Market Feeling About Veru?

Veru's (NASDAQ:VERU) short percent of float has risen 278.79% since its last report. The company recently reported that it has 10.94 million shares sold short, which is 16.97% of all regular shares that are available for trading.

Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Duolingo Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite adding 400 points on Friday.

Benzinga

56 Stocks Moving In Friday's Mid-Day Session

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap: Veru Q2 Earnings

Veru (NASDAQ:VERU) reported its Q2 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

52 Stocks Moving In Wednesday's Mid-Day Session

Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.

Benzinga

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Veru Shares Are Soaring Today Premarket

In a Pre-EUA meeting, FDA said Veru Inc (NASDAQ:VERU) should submit a request for FDA emergency use authorization for sabizabulin in hospitalized COVID-19 patients. The FDA agreed that the Phase 3 COVID-19 study stopped by the Independent Data Monitoring Committee for overwhelming efficacy is sufficient to support the efficacy portion of a request for…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Veru Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 21 strange trades.

Benzinga

5 Short Squeeze Candidates To Watch This Week: Aterian, Harbor Custom Development Remain At The Top, Veru Joins

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

StockNews.com

Up 200% in Just the Past Month, is Veru Stock Still a Buy?

Veru Inc. (VERU) stock has exhibited solid momentum over the past few weeks owing to the company’s recent clinical study of oral medicine sabizabulin, which reduces fatalities by more than 50% in severe COVID-19 patients. However, given Veru’s declining revenue and poor profitability, can the stock sustain its price rally?…

Benzinga

Looking At Veru's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 10 strange trades.

Benzinga

Why Veru May Be Set To Double, Triple In Price And How To Play This Consolidation Pattern

Veru Inc (NASDAQ: VERU) shot up 235% at one point on Monday before closing the trading session up more than 180% off Friday’s closing price. On Tuesday, the stock was consolidating the move higher by setting up an inside bar pattern on the daily chart.

Benzinga

Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the

Benzinga

Why Veru Shares Are Rising After Hours

Veru Inc (NASDAQ: VERU) shares are trading higher in Monday's after-hours session on continued momentum from the regular session.

1 2

People

Heather Cox Richardson

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

341 stories

Pixabay

239 stories

European Medicines Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.